Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02100358
Other study ID # 403462
Secondary ID
Status Completed
Phase N/A
First received March 20, 2014
Last updated May 24, 2017
Start date February 2013
Est. completion date April 2016

Study information

Verified date May 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Functional magnetic resonance cholangiography (fMRC) with gadoxetate disodium (Eovist) is an accurate method of diagnosing acute cholecystitis.


Description:

Primary Objective:

To determine the accuracy of fMRC in evaluating patients with suspected cholecystitis.

Secondary Objective:

To compare the results of fMRC with conventional hepatobiliary scintigraphy.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date April 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Symptoms of right upper quadrant pain with ambiguous US (and/or CT) findings

- Standard of care nuclear medicine hepatobiliary scan to rule out acute cholecystitis -

Exclusion Criteria:

- Scheduled for emergent surgery, or is otherwise determined by the Investigator that the subject is clinically unsuitable for the study

- Glomerular filtration rate (GFR) below 60 mL/min/1.73m2

- Total bilirubin above 3.0 mg/dL

- Inability to provide informed consent (altered or diminished mental status)

- Allergic to morphine

- Known or suspected hypersensitivity to gadolinium-based agents

- The standard MRI contraindications apply, including but not limited to: having a pacemaker or other implanted electronic device, metal foreign bodies within the eye, aneurysm clips, heart valve prosthesis, vascular stents, coils, intrauterine devices (IUDs), penile implants, inferior vena cava (IVC) filters, gunshot wounds with retained bullet fragments.

- Pregnant or breast-feeding -

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States UC Davis Medical Center Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of positive cases of acute cholecystitis The primary outcome measure is the number of positive cases of acute cholecystitis on functional magnetic resonance imaging 2 years
See also
  Status Clinical Trial Phase
Completed NCT04156711 - Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery N/A
Recruiting NCT02130245 - Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study N/A
Completed NCT01942356 - Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor N/A
Completed NCT04995380 - Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
Completed NCT03999645 - Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days? N/A
Completed NCT03296280 - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed NCT03002051 - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent N/A
Completed NCT00447304 - Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy Phase 3
Completed NCT04346550 - Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain N/A
Active, not recruiting NCT04197908 - EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study. N/A
Completed NCT02027402 - Effects of Drainage in Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT01706068 - Transient ECG Changes in Patients With Acute Biliary Disease N/A
Enrolling by invitation NCT04633512 - Safety and Feasibility of ActivSightTM in Human N/A
Completed NCT04672902 - Treatment of Mirizzi Syndrome
Completed NCT03122054 - Early Versus Delayed Cholecystectomy N/A
Recruiting NCT05732480 - Influence of Gut Microbiome in Gallstone Disease
Completed NCT04308265 - Scoring System in Acute Calculous Cholecystitis
Not yet recruiting NCT06287112 - Prevention of Acute Cholecystitis With ETGBD N/A
Recruiting NCT05709548 - Use of Indocyanine Green in Acute Cholecystitis Phase 4
Not yet recruiting NCT06459323 - the Outcomes of Laparoscopic Cholecystectomy for Acute Cholecystitis Within and Beyond the First 72 Hours, Does it Differ?! N/A